30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

HOLTUG LARS

Insider profile

HOLTUG LARS's trades of Ascendis Pharma A/S's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-02 2026-03-02 PrS Proposed sale
23,756
124.75
US$3,649,655
23,756 124.75 US$3,649,655
2025-03-04 2025-03-04 PrS Proposed sale
4,117
396.10
US$659,845
4,117 396.10 US$659,845
2024-03-01 2024-03-01 PrS Proposed sale
20,570
215.58
US$1,107,911
20,570 215.58 US$1,107,911